779 related articles for article (PubMed ID: 17285314)
1. Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.
Aneja R; Dhiman N; Idnani J; Awasthi A; Arora SK; Chandra R; Joshi HC
Cancer Chemother Pharmacol; 2007 Nov; 60(6):831-9. PubMed ID: 17285314
[TBL] [Abstract][Full Text] [Related]
2. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK
Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
[TBL] [Abstract][Full Text] [Related]
3. Determination of glycyrrhetic acid in human plasma by HPLC-MS method and investigation of its pharmacokinetics.
Zhao WJ; Wang BJ; Wei CM; Yuan GY; Bu FL; Guo RC
J Clin Pharm Ther; 2008 Jun; 33(3):289-94. PubMed ID: 18452416
[TBL] [Abstract][Full Text] [Related]
4. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
5. Determination of tegaserod by LC-ESI-MS/MS and its application to a pharmacokinetic study in healthy Chinese volunteers.
Zou JJ; Bian XJ; Ding L; Zhu YB; Fan HW; Xiao DW
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):151-7. PubMed ID: 18069077
[TBL] [Abstract][Full Text] [Related]
6. Validation of an HPLC method for the determination of scutellarin in rat plasma and its pharmacokinetics.
Hao X; Cheng G; Sun J; Zou M; Yu J; Zhang S; Cui F
J Pharm Biomed Anal; 2005 Jun; 38(2):360-3. PubMed ID: 15925232
[TBL] [Abstract][Full Text] [Related]
7. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
[TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatographic determination and pharmacokinetic study of vitexin-2''-O-rhamnoside in rat plasma after intravenous administration.
Ying X; Gao S; Zhu W; Bi Y; Qin F; Li X; Li F
J Pharm Biomed Anal; 2007 Jul; 44(3):802-6. PubMed ID: 17459645
[TBL] [Abstract][Full Text] [Related]
9. HPLC method for the pharmacokinetics and tissue distribution of taspine solution and taspine liposome after intravenous administrations to mice.
Lu W; He LC; Zeng XM
J Pharm Biomed Anal; 2008 Jan; 46(1):170-6. PubMed ID: 17889477
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a high-performance liquid chromatographic method for determination of pinocembrin in rat plasma: application to pharmacokinetic study.
Yang Z; Liu R; Li X; Tian S; Liu Q; Du G
J Pharm Biomed Anal; 2009 Jul; 49(5):1277-81. PubMed ID: 19361943
[TBL] [Abstract][Full Text] [Related]
11. Determination of secnidazole in human plasma by high-performance liquid chromatography with UV detection and its application to the bioequivalence studies.
Li X; Sun J; Wang G; Zheng Y; Yan B; Xie H; Gu Y; Ren H
Biomed Chromatogr; 2007 Mar; 21(3):304-9. PubMed ID: 17221933
[TBL] [Abstract][Full Text] [Related]
12. Determination of nifuratel in human plasma by HPLC and study on its pharmacokinetics.
Wu Y; Xiang B; Yang J; Fu J; Jiang J
J Chromatogr Sci; 2005 Apr; 43(4):179-82. PubMed ID: 15975233
[TBL] [Abstract][Full Text] [Related]
13. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects.
Allen A; Down G; Newland A; Reynard K; Rousell V; Salmon E; Scott R
Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
15. Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent.
Egorin MJ; Zuhowski EG; Sentz DL; Dobson JM; Callery PS; Eiseman JL
Cancer Chemother Pharmacol; 1999; 44(4):283-94. PubMed ID: 10447575
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and distribution of SN 28049, a novel DNA binding anticancer agent, in mice.
Lukka PB; Paxton JW; Kestell P; Baguley BC
Cancer Chemother Pharmacol; 2010 May; 65(6):1145-52. PubMed ID: 19774378
[TBL] [Abstract][Full Text] [Related]
17. Determination of plasma and brain levels of isotretinoin in mice following single oral dose by high-performance liquid chromatography.
Yang Y; Faustino PJ; Pine PS; Davis H; Grunberg N; Phillips J; Lyon RC; Yu LX; Ciavarella AB; Del Grosso AV; Hanig JP
J Pharm Biomed Anal; 2005 Feb; 37(1):157-63. PubMed ID: 15664756
[TBL] [Abstract][Full Text] [Related]
18. Sensitive HPLC method for quantitation of paclitaxel (Genexol in biological samples with application to preclinical pharmacokinetics and biodistribution.
Kim SC; Yu J; Lee JW; Park ES; Chi SC
J Pharm Biomed Anal; 2005 Sep; 39(1-2):170-6. PubMed ID: 16085137
[TBL] [Abstract][Full Text] [Related]
19. Determination of thalidomide by high performance liquid chromatography: plasma pharmacokinetic studies in the rat.
Yang X; Hu Z; Chan SY; Ho PC; Chan E; Duan W; Goh BC; Zhou S
J Pharm Biomed Anal; 2005 Sep; 39(1-2):299-304. PubMed ID: 16085147
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
Li XB; Wu WX; Su D; Wang ZJ; Jiang HY; Shen JZ
J Vet Pharmacol Ther; 2008 Dec; 31(6):523-7. PubMed ID: 19000274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
